Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)

Clinical trial NCT06458036 · RECRUITING

Trial details

NCT number: NCT06458036
Sponsor: Children's Hospital of Philadelphia
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Differentiated Thyroid Cancer Pediatric Cancer Cancer Cancer, Thyroid

Start date: 2024-07-29
Primary completion: 2030-11-01
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.